Ascendis Pharma A/S (ASND)
225.60
-5.10
(-2.21%)
USD |
NASDAQ |
Sep 25, 16:00
225.82
+0.22
(+0.10%)
After-Hours: 19:59
Ascendis Pharma Net Income (Annual) : -257.35M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -257.35M |
| December 31, 2024 | -408.97M |
| December 31, 2023 | -520.50M |
| December 31, 2022 | -612.92M |
| December 31, 2021 | -453.38M |
| December 31, 2020 | -477.60M |
| December 31, 2019 | -244.01M |
| Date | Value |
|---|---|
| December 31, 2018 | -153.48M |
| December 31, 2017 | -139.75M |
| December 31, 2016 | -75.78M |
| December 31, 2015 | -36.51M |
| December 31, 2014 | -12.81M |
| December 31, 2013 | 5.415M |
| December 31, 2012 | 1.606M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| BioMarin Pharmaceutical, Inc. | 348.90M |
| Novo Nordisk A/S | 15.49B |
| Evaxion AS | -7.731M |
| Genmab A/S | 965.95M |
| Zealand Pharma A/S | 976.11M |